TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,082 | -42.6% | 70 | -41.7% | 0.00% | – |
| Q2 2023 | $1,884 | -23.7% | 120 | -20.0% | 0.00% | – |
| Q1 2023 | $2,469 | -47.2% | 150 | -50.0% | 0.00% | – |
| Q4 2022 | $4,680 | -6.4% | 300 | -9.1% | 0.00% | – |
| Q3 2022 | $5,000 | 0.0% | 330 | -8.3% | 0.00% | – |
| Q2 2022 | $5,000 | -44.4% | 360 | -41.9% | 0.00% | – |
| Q1 2022 | $9,000 | 0.0% | 620 | -1.9% | 0.00% | – |
| Q4 2021 | $9,000 | -10.0% | 632 | 0.0% | 0.00% | – |
| Q3 2021 | $10,000 | -9.1% | 632 | 0.0% | 0.00% | – |
| Q2 2021 | $11,000 | -8.3% | 632 | 0.0% | 0.00% | – |
| Q1 2021 | $12,000 | +20.0% | 632 | +14.5% | 0.00% | – |
| Q4 2020 | $10,000 | -16.7% | 552 | -16.6% | 0.00% | – |
| Q3 2020 | $12,000 | -36.8% | 662 | -37.6% | 0.00% | -100.0% |
| Q2 2020 | $19,000 | -69.8% | 1,061 | -74.4% | 0.00% | -50.0% |
| Q1 2020 | $63,000 | -22.2% | 4,139 | +0.7% | 0.00% | 0.0% |
| Q4 2019 | $81,000 | +84.1% | 4,112 | +60.8% | 0.00% | +100.0% |
| Q3 2019 | $44,000 | +2.3% | 2,558 | +5.4% | 0.00% | 0.0% |
| Q2 2019 | $43,000 | -33.8% | 2,427 | -23.8% | 0.00% | -50.0% |
| Q1 2019 | $65,000 | – | 3,187 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |